Skip to main content

Oligo Probe Manufacturing Will Incur Brunt of Layoffs at Third Wave

NEW YORK, April 29 - Third Wave Technologies' manufacturing divisions will be hardest hit as the company starts cutting 25 percent of its workforce in a broader effort to cut costs.

Third Wave, which announced the staff reductions last week, had a headcount of roughly 300 people at the end of 2001. A spokesman said that while the lay offs were "across the board," they do not forecast a departure from genomics research and that all of its product development activities will continue.

Rather, the company "is currently exploring several probe-supply alternatives, such as spinning off, outsourcing and/or otherwise divesting portions of its lower-margin probe manufacturing operations .... " Third Wave said last week of its Wisconsin-based DNA oligonucleotide probe-production facilities.

 

The firm also said it plans to hire more sales and marketing staff to get its products in the marketplace.

"We believe that, ultimately, providing our research customers with greater access to our enzymes at the same time that we're exploring alternatives for supplying them with probes will increase adoption, and with it increase revenue," the spokesman, Rod Hise, said.

Third Wave, based in Madison, said it expects to post more than $10 million in revenue for the first quarter of 2002. The company earned $11 million during the same period one year ago.

A conference call is scheduled for May 7 at 10:00 a.m. Eastern time.

The Scan

Rise of B.1.617.2 in the UK

According to the Guardian, UK officials expect the B.1.617.2 variant to soon be the dominant version of SARS-CoV-2 there.

Anne Schuchat to Retire

Anne Schuchat is retiring after more than 30 years at the US Centers for Disease Control and Prevention, Politico reports.

US to Share More Vaccines

CNN reports that the US will share 20 million doses of the Moderna, Pfizer, and Johnson & Johnson SARS-CoV-2 vaccines with other countries.

PNAS Papers on Gene Therapy Platform, Aspergillus Metabolome, Undernutrition Model Microbiome

In PNAS this week: approach to deliver protein-based treatments to cells, pan-secondary metabolome of Aspergillus, and more.